Home/Pheno Therapeutics/Sohaib Mir, PhD
SM

Sohaib Mir, PhD

Investor Director

Pheno Therapeutics

Pheno Therapeutics Pipeline

DrugIndicationPhase
PTD802Multiple SclerosisPhase 1